By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Becton, Dickinson and Company 

One Becton Drive

Franklin Lakes  New Jersey  07417  U.S.A.
Phone: 201-847-6800 Fax: 201-847-6475


SEARCH JOBS


Industry
Medical Device


Collaborations

PanVera LLC 

Cell Genesys, Inc. (Acquired by BioSante Pharmaceuticals, Inc.)  Vector-licensing agreement in the field of genomics-based drug discovery





Company News
Becton, Dickinson and Company (BDX) Board Declares Dividend 5/24/2017 7:30:14 AM
Becton, Dickinson and Company (BDX) Announces Results Of Early Tenders And Amendments To Exchange Offers 5/19/2017 9:17:22 AM
Becton, Dickinson and Company (BDX) Announces Exercise Of Option To Purchase Additional Shares By Underwriters Of Public Equity Offerings Increasing Total Gross Proceeds To $4.95 Billion 5/12/2017 7:01:38 AM
Becton, Dickinson and Company (BDX) Prices Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock 5/11/2017 8:17:22 AM
Becton, Dickinson and Company (BDX) And UniteOR Join Forces To Deliver An Integrated Tracking Solution For The Operating Room Setting 5/9/2017 11:00:12 AM
Becton, Dickinson and Company (BDX) Announces Offerings Of $2.25 Billion Of Common Stock And $2.25 Billion Of Depositary Shares Representing Interests In Mandatory Convertible Preferred Stock 5/8/2017 9:09:22 AM
Becton, Dickinson and Company (BDX) Announces Commencement Of Exchange Offers And Consent Solicitations For C.R. Bard Notes 5/8/2017 8:12:39 AM
Becton, Dickinson and Company (BDX): What Are Investors To Think Of The Massive $24 Billion C.R. Bard Takeover? 5/4/2017 6:02:05 AM
Becton, Dickinson and Company (BDX) Announces Results For 2017 Second Fiscal Quarter 5/2/2017 10:32:34 AM
Becton, Dickinson and Company (BDX) Advances Efforts To Combat Antimicrobial Resistance With Enhanced Diagnostic Solution Offering 4/28/2017 11:19:50 AM
12345678910...
//-->